Report post

Is Sens stock a 'buy the rumor, sell the fact'?

Some investors took profits after SENS stock jumped in several waves in early 2020. The most recent drop suggests that if the FDA approves Senseonics' diabetes monitoring device, there is room for gains rather than a "buy the rumor, sell the fact." The wait may be nerve-wracking to some, but provides opportunities to others.

Is Sens stock a good long-term investment?

InvestorPlace’s Louis Navellier recently stated that the size of the market — the global diabetes treatment market is estimated to be $42 billion by 2027 — makes SENS stock an excellent long-term bet. I’m not nearly as confident.

Is senseonics (Sens) a good stock to buy?

SENS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good evening and welcome to the […] Senseonics (SENS) delivered earnings and revenue surprises of 25% and 4.99%, respectively, for the quarter ended December 2023.

The World's Leading Crypto Trading Platform

Get my welcome gifts